Delayed and posttreatment immune toxicities in patients with breast cancer receiving immune checkpoint inhibitors

被引：0
|
作者：
Jacob, Saya
Fisch, Samantha
Face, Carolyn
Huppert, Laura
Quandt, Zoe
Quintal, Laura
Melisko, Michelle
Majure, Melanie
Chien, Jo
Blaes, Anne
Rugo, Hope
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PS14-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS14-03
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Influenza vaccination in cancer patients receiving immune checkpoint inhibitors: A systematic review
    Spagnolo, Francesco
    Boutros, Andrea
    Croce, Elena
    Cecchi, Federica
    Arecco, Luca
    Tanda, Enrica
    Pronzato, Paolo
    Lambertini, Matteo
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (07)
  • [32] CARDIAC IMMUNE-RELATED ADVERSE EVENTS IN LUNG CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Kumar, Sany
    Fowler, Cosmo
    Thota, Ajit K.
    Pastores, Stephen M.
    CHEST, 2023, 164 (04) : 363A - 363A
  • [33] Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Hashimoto, Masayuki
    Nakatani, Koichi
    Sawai, Satoru
    Mio, Tadashi
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05):
  • [34] Immune-related Adverse Events in Patients With Cancer Receiving Influenza Vaccination and Immune Checkpoint Inhibitors
    Groeneveld, Geert H.
    Wijn, Dirk H.
    Vollaard, Albert M.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1519 - 1519
  • [35] Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors
    Chong, Curtis R.
    Park, Vivian J.
    Cohen, Bevin
    Postow, Michael A.
    Wolchok, Jedd D.
    Kamboj, Mini
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (02) : 193 - 199
  • [36] The impact of cancer pain on survival of lung cancer patients receiving immune checkpoint inhibitors
    Wang, S.
    Ye, Z-H.
    Zhang, J.
    Lee, T. T. L.
    Wai, A. K. C.
    Kong, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S890 - S890
  • [37] IMPACT OF COVID-19 ON CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Tyan, Kevin
    Bui, Ai-Tram
    Giobbie-Hurder, Anita
    Klein, Isaac
    Manos, Michael
    Zubiri, Leyre
    Reynolds, Kerry
    Grover, Shilpa
    Weinhouse, Gerald
    Ott, Patrick
    LeBoeuf, Nicole
    Rahma, Osama
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A296 - A298
  • [38] INCIDENCE AND PREDICTORS OF CARDIAC TOXICITY IN CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Hu, Jian
    Pappan, Nikos
    Shnoda, Mina
    Doyle, Mark
    Kyvernitakis, Andreas
    Poornima, Indu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3327 - 3327
  • [39] Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Fujita, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [40] Immune-related musculoskeletal toxicities among cancer patients treated with immune checkpoint inhibitors: a systematic review
    Abdel-Rahman, Omar
    Eltobgy, Mostafa
    Oweira, Hani
    Giryes, Anwar
    Tekbas, Aysun
    Decker, Michael
    IMMUNOTHERAPY, 2017, 9 (14) : 1175 - 1183
12345